Results 201 to 210 of about 549,379 (280)

Daily concurrent preoperative chemoradiotherapy using new superselective intra-arterial infusion via superficial temporal artery for oral cancer

open access: bronze, 2007
Noriyuki Yamamoto   +9 more
openalex   +2 more sources

The Clinical Outcomes of Preoperative Self‐Expandable Metal Stent Placement as Bridge to Surgery for Obstructive Colorectal Cancer

open access: yesCancer Reports, Volume 8, Issue 6, June 2025.
ABSTRACT Background Self‐expandable metal stent (SEMS) placement for obstructive colorectal cancer (OCRC) is widely performed as a bridge to surgery because of its lower mortality rate than emergency surgery. However, the long‐term outcomes remain unclear because of the risk of complications and cancer recurrence. This study investigated the short‐ and
Ryosuke Aoki   +9 more
wiley   +1 more source

Hypoxia‐induced PGK1 expression promotes esophageal squamous cell carcinoma progression via stimulating MYH9‐mediated GSK3β/β‐catenin signalling

open access: yesClinical and Translational Medicine, Volume 15, Issue 6, June 2025.
Under hypoxic conditions, elevated PGK1 interacts with MYH9, promoting the ubiquitination and degradation of GSK3β, which leads to β‐catenin stabilisation and nuclear translocation. Activated β‐catenin increases the transcription of c‐Myc and downstream targets genes enhancing cancer stemness, epithelial‐to‐mesenchymal transition (EMT), metastasis, and
Jia‐cheng Xu   +6 more
wiley   +1 more source

Antiseizure medication choice in diffuse glioma: A single‐center population‐based experience

open access: yesEpilepsia Open, Volume 10, Issue 3, Page 705-716, June 2025.
Abstract Objective Several antiseizure medications (ASMs) can be considered as first‐line treatment for glioma‐associated epilepsy (GAE). We aimed to find out, if there are subgroups of glioma patients which may benefit from different first‐line ASMs. Methods All diffuse glioma (grade 2–4) patients, who were in contact with Helsinki University Hospital
Leena Ollila, Reina Roivainen
wiley   +1 more source

Oncological Feasibility of Limited Neck Dissection in cN0 Supraglottic Laryngeal Cancer

open access: yesHead &Neck, Volume 47, Issue 6, Page 1699-1705, June 2025.
ABSTRACT Background Supraglottic squamous cell carcinoma (SCC) is a significant portion of head and neck cancers, with the management of clinically negative necks (cN0) through selective neck dissection (SND) being debated due to potential morbidities and low metastasis rates in levels IIb and IV.
Sara Bassani   +42 more
wiley   +1 more source

Exploratory Research: Patient‐Reported Factors Contributing to Decreased Oral Intake During Radiotherapy in Head and Neck Cancer

open access: yesHead &Neck, Volume 47, Issue 6, Page 1717-1725, June 2025.
ABSTRACT Background Radiotherapy (RT) in head and neck cancer (HNC) can cause multiple side effects such as nausea, pain, taste loss, fatigue, oral mucositis, xerostomia, and acute radiation‐associated dysphagia (RAD). These factors threaten patients' oral intake (OI) during this RT.
Alice Vergauwen   +8 more
wiley   +1 more source

Induction Concurrent Chemoradiotherapy Using Paclitaxel and Carboplatin Combination Followed by Surgery in Locoregionally Advanced Non-Small Cell Lung Cancer – Asian Experience

open access: bronze, 2008
Swee‐Peng Yap   +11 more
openalex   +1 more source

Home - About - Disclaimer - Privacy